Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel

BXRX Insider Trading (Baudax Bio)

Insider Ownership Percentage: 2.60%
Insider Buying (Last 12 Months): $121,430.00
Insider Selling (Last 12 Months): $0.00

Baudax Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Baudax Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Baudax Bio Share Price & Price History

Current Price: $0.60
Price Change: Price Decrease of -0.01 (-1.64%)
As of 09/17/2021 01:00 AM ET

This chart shows the closing price history over time for BXRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel

Baudax Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/31/2021Winston J. ChurchillDirectorBuy100,000$0.63$63,000.00View SEC Filing Icon  
8/20/2021Richard S. CastenCFOBuy50,000$0.51$25,500.00View SEC Filing Icon  
5/14/2021Richard S. CastenCFOBuy25,000$0.79$19,750.00150,000View SEC Filing Icon  
5/11/2021Arnold M. BaskiesDirectorBuy10,000$0.82$8,200.0086,452View SEC Filing Icon  
5/7/2021Geraldine HenwoodCEOBuy6,000$0.83$4,980.00356,307View SEC Filing Icon  
3/26/2020Wayne WeismanDirectorBuy10,000$2.29$22,900.0040,582View SEC Filing Icon  
See Full Table
Insider Selling at Baudax Bio?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Baudax Bio and related companies.

SEC Filings (Institutional Ownership Changes) for Baudax Bio (NASDAQ:BXRX)

8.68% of Baudax Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BXRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Baudax Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/23/2021Morgan Stanley362,339$0.28M0.0%+13,944.1%0.429%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC58,920$45K0.0%+194.1%0.070%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley362,339$0.28M0.0%+13,944.1%0.429%Search for SEC Filing on Google Icon
8/16/2021State Street Corp284,553$0.22M0.0%N/A0.337%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.151,323$0.12M0.0%N/A0.179%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC534,792$0.41M0.0%+30.7%0.634%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.3,727,800$2.84M0.0%-4.1%4.417%Search for SEC Filing on Google Icon
5/17/2021Edmond DE Rothschild Holding S.A.100,000$0.13M0.0%N/A0.143%Search for SEC Filing on Google Icon
5/14/2021MML Investors Services LLC45,000$58K0.0%N/A0.064%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp101,229$0.13M0.0%N/A0.144%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp170,876$0.22M0.0%+158.8%0.244%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC409,190$0.53M0.0%+460.4%0.583%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,445,238$1.87M0.0%+735.8%2.060%Search for SEC Filing on Google Icon
2/24/2021Alyeska Investment Group L.P.80,870$82K0.0%N/A0.115%Search for SEC Filing on Google Icon
2/16/2021Alyeska Investment Group L.P.80,870$82K0.0%N/A0.190%Search for SEC Filing on Google Icon
2/16/2021Armistice Capital LLC3,503,351$3.54M0.1%N/A4.995%Search for SEC Filing on Google Icon
2/16/2021Corsair Capital Management L.P.90,752$92K0.0%-79.0%0.213%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC422,200$0.43M0.0%+1,096.0%0.990%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP221,287$0.22M0.0%N/A0.519%Search for SEC Filing on Google Icon
11/16/2020Oberweis Asset Management Inc.133,160$0.37M0.1%-15.3%0.507%Search for SEC Filing on Google Icon
11/12/2020Arrowstreet Capital Limited Partnership227,314$0.63M0.0%-13.9%1.237%Search for SEC Filing on Google Icon
9/15/2020Schonfeld Strategic Advisors LLC10,200$42K0.0%N/A0.056%Search for SEC Filing on Google Icon
8/17/2020Jane Street Group LLC39,636$0.16M0.0%N/A0.216%Search for SEC Filing on Google Icon
8/14/2020Man Group plc12,490$52K0.0%N/A0.068%Search for SEC Filing on Google Icon
8/14/2020Verition Fund Management LLC27,000$0.11M0.0%N/A0.147%Search for SEC Filing on Google Icon
8/14/2020Ikarian Capital LLC100,000$0.42M0.0%N/A0.544%Search for SEC Filing on Google Icon
8/14/2020Advisor Group Holdings Inc.10,123$41K0.0%N/A0.055%Search for SEC Filing on Google Icon
8/13/2020Johnson Investment Counsel Inc.10,000$42K0.0%N/A0.057%Search for SEC Filing on Google Icon
8/12/2020Goldman Sachs Group Inc.10,094$42K0.0%N/A0.057%Search for SEC Filing on Google Icon
8/12/2020Bank of New York Mellon Corp11,861$49K0.0%N/A0.068%Search for SEC Filing on Google Icon
8/12/2020Commonwealth Equity Services LLC163,364$0.68M0.0%N/A0.930%Search for SEC Filing on Google Icon
8/12/2020California Public Employees Retirement System27,200$0.11M0.0%N/A0.155%Search for SEC Filing on Google Icon
8/3/2020Leap Investments LP19,000$79K0.1%N/A0.108%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG5,929$25K0.0%N/A0.034%Search for SEC Filing on Google Icon
7/23/2020Creative Planning25,000$0.10M0.0%N/A0.142%Search for SEC Filing on Google Icon
6/19/2020State Street Corp169,815$0.42M0.0%N/A0.967%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Baudax Bio logo
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine, which is under phase II clinical trial. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
Read More on Baudax Bio

Today's Range

Now: $0.60
Low: $0.58
High: $0.62

50 Day Range

MA: $0.62
Low: $0.51
High: $0.71

52 Week Range

Now: $0.60
Low: $0.50
High: $3.56

Volume

1,200,000 shs

Average Volume

3,846,440 shs

Market Capitalization

$50.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.28

Who are the company insiders with the largest holdings of Baudax Bio?

Baudax Bio's top insider shareholders include:
  1. Geraldine Henwood (CEO)
  2. Richard S Casten (CFO)
  3. Arnold M Baskies (Director)
  4. Wayne Weisman (Director)
  5. Winston J Churchill (Director)

Who are the major institutional investors of Baudax Bio?

Baudax Bio's top institutional shareholders include:
  1. Vanguard Group Inc. — 4.42%
  2. Geode Capital Management LLC — 0.63%
  3. Morgan Stanley — 0.43%
  4. Morgan Stanley — 0.43%
  5. State Street Corp — 0.34%
  6. Goldman Sachs Group Inc. — 0.18%

Which institutional investors are selling Baudax Bio stock?

Within the last quarter, BXRX stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. Susquehanna International Group LLP

Which institutional investors are buying Baudax Bio stock?

During the last quarter, BXRX stock was bought by institutional investors including:
  1. Morgan Stanley
  2. Morgan Stanley
  3. State Street Corp
  4. Goldman Sachs Group Inc.
  5. Geode Capital Management LLC
  6. Millennium Management LLC
  7. Simplex Trading LLC
Within the previous year, these company insiders have bought Baudax Bio stock:
  1. Geraldine Henwood (CEO)
  2. Richard S Casten (CFO)
  3. Arnold M Baskies (Director)
  4. Wayne Weisman (Director)
  5. Winston J Churchill (Director)
Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel